Heusse J-L, Hivelin M, Lepage C, Santini C, Lantieri L
Service de chirurgie plastique, hôpital Sud, 16, boulevard de Bulgarie, BP 90347, 35203 Rennes cedex 2, France.
Ann Chir Plast Esthet. 2012 Feb;57(1):50-8. doi: 10.1016/j.anplas.2010.10.013. Epub 2011 Jan 14.
Serosanguinous drainage after breast reconstruction by deep inferior epigastric perforator (DIEP) flap constitute with the microsurgical monitoring, the main limiting factors for patient discharge. Fibrin sealant has already been studied to reduce post breast surgery drainage. The authors are presenting their experience in secondary breast reconstruction by DIEP flap with the use of sprayed fibrin sealant.
Twenty-one female patients aged 28 to 63 years old who underwent secondary breast reconstruction after mastectomy for cancer between October 2004 and June 2007 have been reviewed. These patients were separated into two groups. In group 1, patients (n=9) received two drains placed under the flap and in the axillary area. In group 2, (n=12) the DIEP flaps and thoracic areas were sprayed with fibrin sealant (Tissucol(®)) before the two drains inset.
No adverse effect were reported, with a 36-month median follow-up. Drainages volumes or durations were not correlated to the patients' Body Mass Index (BMI). Lower drained volumes were collected from the thoracic region (372ml versus 629mL) and thoracic drains were removed earlier (5.5 days versus 6.9 days) in group 2. The length of stay was also significantly reduced after fibrin sealant use (5.5 days versus 7.22 days with P=0.0305 by log rank test).
This study is a rare clinical one on fibrin sealant use to decrease postoperative drainage in breast reconstruction by DIEP flap. Fibrin sealant significantly decreased the postoperative drainage volume and duration.
采用腹壁下深动脉穿支(DIEP)皮瓣进行乳房重建术后的血清样引流,连同显微外科监测一起,是限制患者出院的主要因素。已经对纤维蛋白封闭剂进行了研究,以减少乳房手术后的引流。作者介绍了他们在使用喷雾型纤维蛋白封闭剂进行DIEP皮瓣二期乳房重建方面的经验。
回顾了2004年10月至2007年6月间因癌症行乳房切除术后接受二期乳房重建的21例年龄在28至63岁之间的女性患者。这些患者被分为两组。在第1组中,患者(n = 9)在皮瓣下和腋窝区域放置了两根引流管。在第2组中(n = 12),在插入两根引流管之前,对DIEP皮瓣和胸部区域喷洒了纤维蛋白封闭剂(Tissucol(®))。
在36个月的中位随访期内,未报告不良反应。引流体积或持续时间与患者的体重指数(BMI)无关。第2组从胸部区域收集到的引流量较低(372ml对629mL),胸部引流管拔除时间较早(5.5天对6.9天)。使用纤维蛋白封闭剂后住院时间也显著缩短(5.5天对7.22天,对数秩检验P = 0.0305)。
本研究是一项罕见的关于使用纤维蛋白封闭剂减少DIEP皮瓣乳房重建术后引流的临床研究。纤维蛋白封闭剂显著减少了术后引流体积和持续时间。